NASDAQ:QIPT - Nasdaq - CA74880P1045 - Common Stock - Currency: USD
2.14
0 (0%)
The current stock price of QIPT is 2.14 USD. In the past month the price increased by 0.94%. In the past year, price decreased by -46.9%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.06 | 90.31B | ||
CVS | CVS HEALTH CORP | 10.67 | 85.65B | ||
LH | LABCORP HOLDINGS INC | 16.89 | 20.82B | ||
DGX | QUEST DIAGNOSTICS INC | 19.14 | 19.64B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 17.54 | 16.47B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 128.11 | 13.91B | ||
HIMS | HIMS & HERS HEALTH INC | 74.49 | 11.50B | ||
DVA | DAVITA INC | 15.12 | 11.04B | ||
CHE | CHEMED CORP | 24.14 | 8.33B | ||
CRVL | CORVEL CORP | 26.85 | 5.76B | ||
OPCH | OPTION CARE HEALTH INC | 23.31 | 5.19B | ||
GH | GUARDANT HEALTH INC | N/A | 5.16B |
Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. The company is headquartered in Wilder, Kentucky. The company went IPO on 2014-03-18. The firm provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. The Company’s comprehensive solutions support patients dealing with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. The firm serves patients approximately 26 states in the United States. The firm's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, home medical equipment, and custom mobility solutions.
QUIPT HOME MEDICAL CORP
1019 Town Drive
Wilder KENTUCKY US
CEO: Gregory Crawford
Employees: 1200
Phone: 18598782220
The current stock price of QIPT is 2.14 USD.
The exchange symbol of QUIPT HOME MEDICAL CORP is QIPT and it is listed on the Nasdaq exchange.
QIPT stock is listed on the Nasdaq exchange.
9 analysts have analysed QIPT and the average price target is 6.52 USD. This implies a price increase of 204.71% is expected in the next year compared to the current price of 2.14. Check the QUIPT HOME MEDICAL CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
QUIPT HOME MEDICAL CORP (QIPT) has a market capitalization of 92.21M USD. This makes QIPT a Micro Cap stock.
QUIPT HOME MEDICAL CORP (QIPT) currently has 1200 employees.
QUIPT HOME MEDICAL CORP (QIPT) has a support level at 1.98 and a resistance level at 2.14. Check the full technical report for a detailed analysis of QIPT support and resistance levels.
The Revenue of QUIPT HOME MEDICAL CORP (QIPT) is expected to decline by -3.59% in the next year. Check the estimates tab for more information on the QIPT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
QIPT does not pay a dividend.
QUIPT HOME MEDICAL CORP (QIPT) will report earnings on 2025-05-12, after the market close.
QUIPT HOME MEDICAL CORP (QIPT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.14).
The outstanding short interest for QUIPT HOME MEDICAL CORP (QIPT) is 4.2% of its float. Check the ownership tab for more information on the QIPT short interest.
ChartMill assigns a technical rating of 1 / 10 to QIPT. When comparing the yearly performance of all stocks, QIPT is a bad performer in the overall market: 89.19% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to QIPT. Both the profitability and financial health of QIPT have multiple concerns.
Over the last trailing twelve months QIPT reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS decreased by -55.56% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.99% | ||
ROE | -6.83% | ||
Debt/Equity | 0.74 |
ChartMill assigns a Buy % Consensus number of 82% to QIPT. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 32% and a revenue growth -3.59% for QIPT